Strategic CDMO Freudenberg Medical positions itself as a strategic CDMO partner with end-to-end capabilities from ideation to market launch and volume production. This suggests opportunities to engage for full product development programs, platform technologies, and robust manufacturing scale for device and component production.

Global footprint With over 2,900 associates across 12 global manufacturing sites, the company can support multinational programs requiring diverse compliance postures and regional manufacturing. This is advantageous for customers seeking risk diversification, global supply continuity, and local production in key MedTech hubs.

Coatings and materials The portfolio includes drug and hydrophilic coatings, silicone, thermoplastics, and metals with capabilities in hydrophilic coatings like LUBRITEQ. This creates upsell opportunities in surface engineering, biocompatible coatings, and advanced extrusion or molding for catheter and minimally invasive devices.

Recent expansions Recent openings in Costa Rica and restructuring in California indicate ongoing capacity expansion and optimization. This signals potential for new manufacturing capacity to take on growth programs, as well as opportunities to consolidate or relocate projects to optimize cost and speed to market.

Cleanroom readiness Launch of CleanAssure ISO Class 5 controlled cleanroom for sterile single-use assemblies highlights strength in sterile manufacturing and quality systems. This can be leveraged to target customers with strict sterility requirements and high-volume, single-use device programs seeking reliable aseptic production.